|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Karolinska Institutet |
|---|---|
| Information provided by: | Karolinska Institutet |
| ClinicalTrials.gov Identifier: | NCT01160406 |
Purpose
The aim of the study is to assess the incidence of patients suffering from ischemic stroke or transient ischemic attacks who have underlying asymptomatic paroxysmal atrial fibrillation.
Patients who have suffered an ischemic stroke or transient ischemic attack, without a history of atrial fibrillation, are planned to be included. Starting within 14 days of the ischemic stroke, participating patients are asked to perform 10 second ECG recordings using a handheld ECG device twice daily (mornings and evenings) during 30 days. These recordings are transmitted via telephone to a secure encrypted Internet site. Within these 30 days the participants also perform an ambulatory 24 hour Holter recording. Handheld ECG recordings are evaluated continuously. In case of atrial fibrillation the patient is informed and offered treatment with anti coagulant medication (Warfarin). The investigation is a comparison between 24 hour continuous ECG recordings and short intermittent ECG recordings twice daily over a longer time period to determine which method is the best to detect atrial fibrillation in this patient group.
Hypothesis: Short Intermittent ECG recordings over a longer time period is more efficient, compared with continuous 24 hour ECG recordings, in detecting silent paroxysmal AF in patients with an ischemic stroke and without a history of atrial fibrillation.
| Condition |
|---|
|
Atrial Fibrillation Stroke |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Improving Screening for Silent Atrial Fibrillation, After Ischemic Stroke |
| Estimated Enrollment: | 250 |
| Study Start Date: | June 2007 |
| Study Completion Date: | November 2010 |
| Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
ischemic stroke, no atrial fibrillation
Patients who have suffered ischemic stroke or transient ischemic attack without known atrial fibrillation
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients from hospital strokewards.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Sweden | |
| Halmstad hospital | |
| Halmstad, Halland, Sweden, 30180 | |
| Danderyds hospital AB | |
| Stockholm, Sweden, 18288 | |
| South hospital | |
| Stockholm, Sweden, 11883 | |
| Study Director: | Mårten Rosenqvist, M.D.Ph.D. | Karolinska Institutet |
More Information
| Responsible Party: | Mårten Rosenqvist M.D. Ph.D., Karolinska Institutet |
| ClinicalTrials.gov Identifier: | NCT01160406 History of Changes |
| Other Study ID Numbers: | KI-DSAB-2010 |
| Study First Received: | July 9, 2010 |
| Last Updated: | June 22, 2011 |
| Health Authority: | Sweden: The National Board of Health and Welfare |
|
silent paroxysmal atrial fibrillation stroke tele ECG |
|
Atrial Fibrillation Stroke Cerebral Infarction Arrhythmias, Cardiac Heart Diseases Cardiovascular Diseases Pathologic Processes |
Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Vascular Diseases Brain Infarction Brain Ischemia |